- Home
- PTGX vs TALO Comparison
PTGX vs TALO Comparison
Compare PTGX & TALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | TALO |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 1.8B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTGX | TALO |
|---|---|---|
| Price | $84.67 | $11.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $93.00 | $14.30 |
| AVG Volume (30 Days) | 756.7K | ★ 1.6M |
| Earning Date | 02-20-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | $209,217,000.00 | ★ $1,872,554,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $409.41 | N/A |
| P/E Ratio | $116.48 | ★ N/A |
| Revenue Growth | N/A | ★ 0.06 |
| 52 Week Low | $33.70 | $6.23 |
| 52 Week High | $96.54 | $12.32 |
Technical Indicators
Market Signals| Indicator | PTGX | TALO |
|---|---|---|
| Relative Strength Index (RSI) | 49.78 | 51.45 |
| Support Level | $79.87 | $11.05 |
| Resistance Level | $87.44 | $11.77 |
| Average True Range (ATR) | 3.42 | 0.47 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 61.35 | 46.31 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.